Posts by tag
CancerWorld
CancerWorld #118 (August 2026)
We often describe progress in oncology through the language of discovery. Scientific breakthroughs. Technological innovation. Deeper biological insight. These advances have transformed medicine, helping millions of people live longer and better than ever before. Yet alongside every scientific breakthrough, a…
Could GLP-1 Drugs Slow Cancer Spread? New Study Offers Encouraging Clues
Treatment with GLP-1 receptor agonists (GLP-1RAs) was associated with a significantly lower risk of progression to metastatic disease in non–small cell lung cancer (NSCLC), breast cancer, colorectal cancer (CRC), and hepatocellular carcinoma (HCC). The study, presented at the 2026 American…
Behind Every Drug There Is a Story: Brian Druker, Imatinib, and the Human Journey Behind a Revolution in Cancer Care
Twenty-five years after imatinib transformed chronic myeloid leukaemia from a fatal diagnosis into a manageable disease for many patients, Brian Druker reflects on the curiosity, setbacks, and patients who shaped one of oncology's greatest breakthroughs. Long before I understood the…
Beyond Treatment: Why Psycho-Oncological Education Matters for Patients and Their Caregivers
"Cancer is part of a person's life, but it should never become their entire identity." That simple yet powerful observation from global cancer advocate Carmen Monge-Montero captures a growing recognition in oncology: treating cancer successfully requires more than surgery, chemotherapy,…
Finding a Voice Beyond Cancer: How Karen Nakawala transformed a cervical cancer diagnosis into a movement for survivor leadership and better cancer care
Karen Nakawala spent decades telling other people's stories. As one of Zambia's well-known broadcasters, she knew how to command a microphone, connect with audiences and give voice to people whose experiences might otherwise go unheard. Whether presenting a live radio…
Global Inequalities in Access to Radiation Treatment
Millions of cancer patients live within reach of life saving radiation treatment. Millions more live nowhere near it. The research maps just how wide, and how consequential, that gap has become. Radiotherapy is a cornerstone of modern cancer care. Around…
When RAS Becomes Treatable: Eileen O’Reilly on daraxonrasib in Pancreatic Cancer
Daraxonrasib nearly doubled median survival in previously treated metastatic pancreatic cancer. For Dr Eileen O’Reilly, the result is not simply a remarkable curve on a conference screen, but the beginning of a new way to think about a disease long…
From Treating Children to Shaping Global Cancer Policy: Dr Tezer Kutluk on Leadership, Equity, and the Future of Oncology
Over four decades, Dr Tezer Kutluk, Scientific Director of Medicana Health group and Chair of the Department of Pediatric Oncology at Medicana Hospitals, Turkey, has witnessed the transformation of cancer care—from the early days of pediatric oncology to the era…
Daraxonrasib: A Turning Point for Pancreatic Cancer
Pancreatic ductal adenocarcinoma remains one of the most difficult cancers to treat, with limited progress in drug development over the past decade. At the 2026 ASCO Annual Meeting, the Phase 3 RASolute 302 trial delivered results that stood out against…
Doctor of Hope
How Professor Nagi El Saghir Changed the Language of Cancer in the Middle East and Helped Redefine Global Oncology The airport in Beirut looked very different in 1971. Families walked all the way to the aircraft. Parents accompanied their children…